You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DFTX Sale Disclosure
Sullivan Mark · SEC Form 4 · Filed Jun 26, 2026
Sale
Calculated transaction value
$585.75K
Sullivan Mark Chief Legal Officer
DFTX
Transaction date
Jun 25, 2026
Public filing date
Jun 26, 2026
Filing lag
Filed 1 day later
DFTX daily price context
Close on/before transaction
$44.79
Jun 25, 2026
First close after public filing
$46.55
Jun 29, 2026
30-day return after filing
-8.38%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 13,008 shares @ $45.03
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-285567
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$585.75K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Definium Therapeutics, Inc. DFTX Current | Sale | Jun 25, 2026 | $585.75K |